Acknowledgments
The authors would like to acknowledge the members of the AES Q-PULSE Task Force who created the survey instrument: Nicholas Beimer, MD; Mesha-Gay Brown, MD; Brian T. Cabaniss, MD; Cristina Y. Go, MD; Kyung-Wha Kim, MD; Katherine Noe, MD, PhD; Imran H. Quraishi, MD, PhD; Tung Tran, MD; Daniel Winkel, MD. The authors would also like to acknowledge the members of the AES Guidelines and Assessments Committee and Council on Clinical Activities who reviewed this manuscript: Naoki Akamatsu, MD, PhD; Christine Baca, MD; Michael Gelfand, MD, PhD; Emily L. Johnson, MD; Lisa V. Knopf, MD; Appaji Rayi, MD; John M. Stern, MD, MA; Elissa Yozawitz, MD; Barry Gidal, PharmD; Anup Patel MD, MBA; and Timothy Welty, PharmD. Finally, the authors would like to acknowledge Penny Dacks, PhD, AES Associate Executive Director, for her support for this project. Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article. J.N.A: Consultant for SK Lifescience. J.W.L: Cash compensation from Digitrace and Teladoc; grant from Enagage Therapeutics; co-founder of Soterya Inc. J.R.P: Stock ownership in Cognizance biomarkers, LLC. A.M.H: Editor for Journal of Clinical Neurophysiology; scientific advisory board or consultant for Marinus Pharmaceuticals, UCB Pharmaceuticals, Jazz Pharmaceuticals, Sage Therapeutics, Eisai Pharmaceuticals, and Neurelis Pharmaceuticals; royalties from Springer Publishers, Demos Medical Publishing, and Wolters Kluwer; research support from Marinus Pharmaceuticals, Sage Therapeutics, Biogen Idec, and UCB Pharmaceuticals.
Funding: The author(s) received no financial support for the research, authorship, and/or publication of this article.
ORCID iD: Joy A. Keller  https://orcid.org/0000-0002-1483-6859
Aatif M. Husain  https://orcid.org/0000-0001-7954-1755
Supplemental Material: Supplemental material for this article is available online.